TA
ACHN

Teachers Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Teachers Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6.68M Buy
2,257,167
+498,654
+28% +$1.23M 0.01% 1218
2018
Q4 		$2.8M Buy
1,758,513
+2,070
+0.1% +$5.85K ﹤0.01% 1643
2018
Q3 		$6.46M Buy
1,756,443
+22,478
+1% +$67K 0.01% 1295
2018
Q2 		$4.91M Buy
1,733,965
+240,699
+16% +$820K 0.01% 1437
2018
Q1 		$5.54M Sell
1,493,266
-58,998
-4% -$193K 0.01% 1286
2017
Q4 		$4.47M Buy
1,552,264
+57,782
+4% +$210K 0.01% 1411
2017
Q3 		$6.71M Buy
1,494,482
+69,100
+5% +$307K 0.01% 1190
2017
Q2 		$6.54M Buy
1,425,382
+77,524
+6% +$312K 0.01% 1197
2017
Q1 		$5.67M Buy
1,347,858
+404,317
+43% +$1.68M 0.01% 1240
2016
Q4 		$3.9M Buy
943,541
+177,537
+23% +$944K 0.01% 1404
2016
Q3 		$6.21M Buy
766,004
+578,300
+308% +$4.92M 0.01% 1124
2016
Q2 		$1.46M Buy
187,704
+13,952
+8% +$120K ﹤0.01% 1838
2016
Q1 		$1.34M Hold
173,752
– – ﹤0.01% 1830
2015
Q4 		$1.88M Sell
173,752
-318,550
-65% -$2.9M ﹤0.01% 1634
2015
Q3 		$3.4M Buy
492,302
+2,881
+0.6% +$23.5K 0.01% 1280
2015
Q2 		$4.34M Buy
489,421
+5,643
+1% +$53.4K 0.01% 1228
2015
Q1 		$4.77M Buy
483,778
+30,959
+7% +$387K 0.01% 1179
2014
Q4 		$5.55M Sell
452,819
-67,260
-13% -$821K 0.01% 1104
2014
Q3 		$5.19M Buy
520,079
+31,800
+7% +$295K 0.01% 1123
2014
Q2 		$3.7M Buy
488,279
+338,476
+226% +$1.35M 0.01% 1264
2014
Q1 		$493K Hold
149,803
– – ﹤0.01% 2411
2013
Q4 		$497K Buy
149,803
+16,980
+13% +$49.3K ﹤0.01% 2385
2013
Q3 		$401K Buy
132,823
+3,761
+3% +$25.8K ﹤0.01% 2456
2013
Q2 		$1.06M Buy
+129,062
New +$985K ﹤0.01% 1825

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teachers Advisors's ACHN Position: Q1 2019 in Review

Teachers Advisors increased its Achillion Pharmaceuticals (ACHN) stake by 28% in Q1 2019, buying an estimated $1.23M and bringing the position to 2,257,167 shares worth $6.68M. The position accounts for 0.01% of the portfolio, ranked #1218.

Teachers Advisors first reported a position in ACHN in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.71M in Q3 2017. 110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

  • Teachers Advisors held 2,257,167 shares of Achillion Pharmaceuticals worth $6.68M as of Q1 2019.
  • Teachers Advisors bought 498,654 Achillion Pharmaceuticals shares in Q1 2019, an estimated $1.23M.
  • Achillion Pharmaceuticals made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1218 holding.
  • Teachers Advisors first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Achillion Pharmaceuticals position peaked at $6.71M in Q3 2017.
  • 110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.